Overview
- A two‑day visit in Mexico City ended with a Joint Declaration and sectoral memorandums covering health, agriculture, biocombustibles, energy and investment promotion.
- Cofepris and Brazil’s Anvisa signed a memorandum to pursue mutual recognition of regulatory capacities, expediting sanitary registrations, clinical trials and joint certification of pharmaceutical plants.
- Birmex and Brazil’s Fiocruz agreed to cooperate on producing vaccines, active pharmaceutical ingredients and strategic medicines, with coordinated action against dengue including use of the Butantan vaccine and shared surveillance.
- A Mexico–Brazil Health Committee will be created to track implementation and will meet monthly to convert the accords into concrete projects.
- Mexico and Brazil launched a 12‑month review to update ACE 53/55 and an investment facilitation framework with a target signature by mid‑2026, as President Claudia Sheinbaum ruled out a free‑trade pact and hosted a large Brazilian business delegation; Mexico City also granted Vice President Geraldo Alckmin the Keys to the City.